Evidence map›Paper›PMID 39576000›Full record

Observational studyJournal of gynecologic oncology2025

Shared decision-making in patients with gynecological cancer and healthcare professionals: a cross-sectional observational study in Japan.

Masakazu Abe, Hironobu Hashimoto, Azusa Soejima, Yumiko Nishimura, Ami Ike, Michiko Sugawara, Muneaki Shimada

Abstract readObservational Study
In one paragraph

Observational study in Journal of gynecologic oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Reproductive concerns and quality of life among Chinese women undergoing fertility-sparing surgery for gynecologic malignancies: a mixed-methods study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masakazu AbeDepartment of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.ORCID 0000-0002-8508-3997
Hironobu HashimotoDepartment of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0002-5907-5547
Azusa SoejimaDepartment of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID 0009-0009-3266-573X
Yumiko NishimuraDepartment of Nursing, The Hospital of Hyogo College of Medicine, Nishinomiya, Japan.ORCID 0009-0001-0613-6561
Ami IkeEisai Co., Ltd., Tokyo, Japan.ORCID 0009-0003-2271-7547
Michiko SugawaraEisai Co., Ltd., Tokyo, Japan.ORCID 0009-0001-7734-6611
Muneaki ShimadaDepartment of Gynecology, Tohoku University Hospital, Sendai, Japan.ORCID 0000-0003-1826-6723

Funding

Eisai
6 · The paper itself

Abstract

objectiveThis cross-sectional study aimed to understand the actual situation of shared decision-making (SDM) and identify the challenges of implementing SDM among Japanese gynecologic cancer patients and healthcare professionals (HCPs).

methodsAdult Japanese women undergoing chemotherapy for endometrial or ovarian/fallopian tube cancer and HCPs who prescribed/administered treatment were enrolled. Data were collected via a web-based questionnaire. Primary endpoints were the actual and desired status of SDM for patients by preferred role (active, collaborative, passive), and important aspects in drug selection for patients and HCPs. SDM treatment preferences were determined using the Control Preferences Scale.

resultsRespondents comprised 154 patients (77 for endometrial and 77 for ovarian/fallopian tube cancer), 153 physicians, 166 nurses, and 154 pharmacists. Among patients, 53.9% desired an active role in decision-making, and 55.8% participated; 25.3% desired a collaborative role, and 14.3% participated; and 20.8% desired a passive role, and 29.9% participated. Most patients with a collaborative role in decision-making (86.4%) were "very satisfied" or "somewhat satisfied" with their communication with physicians, compared with 60.4% and 73.9% of respondents with active and passive roles in decision-making, respectively. In daily practice, 23.5%, 47.6%, and 19.5% of physicians, nurses, and pharmacists, respectively, confirmed "awareness" of SDM. Regarding treatment expectations, patients ranked "complete elimination of cancer," and HCPs ranked "live longer" as the most important.

conclusionMost patients desire involvement in their treatment decisions. Additionally, treatment expectations differ between patients and HCPs. Increasing SDM awareness, implementing it systematically, and addressing patients' needs for collaborative roles in decision-making is essential.

Indexed as

Decision Making, SharedGenital Neoplasms, FemalePatient ParticipationAdultAgedCross-Sectional StudiesFemaleHealth PersonnelHumansJapanMiddle AgedPatient PreferencePharmacistsSurveys and QuestionnairesCross-Sectional StudiesDecision MakingEndometrial CancerGynecologic NeoplasmsOvarian Cancer

Identifiers

PMID39576000
PMCPMC12099051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.